Anorectal Disease. Disease of anus and rectum, unspecified
Conditions
Interventions
Intervention 1: In pudendal nerve block group, 5 milliliter marcaine 0.5% diluted with normal saline to reach the volume of 8cc administered in clock 3 and 9 of perianal area. The patients’ pain score
Treatment - Drugs
In pudendal nerve block group, 5 milliliter marcaine 0.5% diluted with normal saline to reach the volume of 8cc administered in clock 3 and 9 of perianal area. The patients’ pain score were checked ev
In patient controlled analgesia group, patients connected to a pomp containing 20 mg morphine sulphate diluted in 100 cc normal saline adjusted infusion rate at 4cc/hour and 1cc for bolus every 15 min
Sponsors
Vice chancellor for research, Shahid Beheshti University of Medical Sciences
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: Inclusion Criteria: Patients with American Society of Anesthesiologists (ASA) Class I or II; candidate for elective anorectal surgery under general anesthesia Exclusion Criteria: Pregnancy; opium addiction; documented cardiovascular or pulmonary disease; allergy to the drugs using in trial
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Pain. Timepoint: 0, 6, 12, 24 hours after surgery. Method of measurement: Numerical Rating Scale (NRS).;Patient Satisfaction. Timepoint: Until 24 hours after surgery. Method of measurement: Numerical Rating Scale (NRS). | — |
Secondary
| Measure | Time frame |
|---|---|
| Side effects. Timepoint: Until 24 hours after surgery. Method of measurement: Serial physical exam. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactDr. Alireza Baratloo
Shahid Beheshti University of Medical Sciences
Outcome results
None listed